Search
Vinorelbine
go.drugbank.com/drugs/DB00361ApprovedInvestigationalVinorelbine is an anti-mitotic chemotherapy drug that is used in the treatment of several types of malignancies, including breast cancer and non-small cell lung cancer (NSCLC) . It was initially approved in the USA in 1990's for the trea...
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2D6 InhibitorsSynonyms: 5'-NoranhydrovinblastineInsulin human
go.drugbank.com/drugs/DB00030ApprovedInvestigationalHuman Insulin is a 51 residue peptide hormone produced by recombinant DNA technology by inserting the human insulin gene into Escherichia coli bacteria or Saccharomyces cerevisiae. … The structure is identical to native human insulin, with two amino acid chains covalently linked by disulfide bonds.
Mixtures: GENSULIN M 40 (40/60) 100 IU/ML, GENSULIN M 40 (40/60) 100 IU/MLCategories: Cytochrome P-450 CYP1A2 Inducers, Cytochrome P-450 Enzyme InducersTorasemide
go.drugbank.com/drugs/DB00214ApprovedInvestigational[A319] Torasemide was first approved for clinical use by the FDA in 1993.[L5257]
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2C8 SubstratesSynonyms: 1-Isopropyl-3-((4-m-toluidino-3-pyridyl)sulfonyl)ureaCetuximab
go.drugbank.com/drugs/DB00002ApprovedInvestigational[A228083] _In vitro_, cetuximab was shown to mediate anti-tumour effects in numerous cancer cell lines and human tumour xenografts. … Cetuximab is a recombinant chimeric human/mouse IgG1 monoclonal antibody that competitively binds to epidermal growth factor receptor (EGFR) and competitively inhibits the binding of epidermal growth factor
Products: ERBITUX 500 MG/100 ML IV INFUZYON ICIN COZELTI ICEREN FLAKON, 1 ADET, ERBITUX 100 MG/20 ML IV INFUZYON ICIN COZELTI ICEREN FLAKON, 1 ADETDaratumumab
go.drugbank.com/drugs/DB09331ApprovedInvestigational[A199002] Daratumumab was granted FDA approval on 16 November 2015. … Daratumumab is an immunoglobulin G1 kappa monoclonal antibody developed by Janssen and Genmab.
Products: DARZALEX 100 MG/5 ML İNFÜZYONLUK ÇÖZELTİ HAZIRLAMAK İÇİN KONSANTRE, DARZALEX® SC 120 MG/ML SOLUCIÓN INYECTABLEBevacizumab
go.drugbank.com/drugs/DB00112ApprovedInvestigationalEMA in July 2024 to treat several cancer types. … [L45793,L43130] For over a decade, bevacizumab was also used off-label by intravitreal injection to treat neovascular (wet) age-related macular degeneration and other retinal conditions, repackaged from
International brands: Ai Rui TuoProducts: ZIRABEV CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/4 ML, ZİRABEV 100 MG/4 ML İNFÜZYONLUK ÇÖZELTİ, 1 ADETDextran
go.drugbank.com/drugs/DB09255ApprovedInvestigationalVet approved[A32011] Many bacteria, like _Leuconostoc_, can synthesize dextran from sucrose, and this activity is used commercially to obtain dextran. … When labelled with technetium Tc99m, dextran 75 is intravenously administered as an imaging agent to detect and diagnose conditions in the vascular compartment such as pericardial effusion or ventricular
Salts: Dextran 40, Dextran 70Mixtures: POLİFLEKS 100 MG/ML DEKSTRAN 40+9 MG/ML İZOTONİK SODYUM KLORÜR I.V. İNFÜZYON İÇİN ÇÖZELTİ, 100 ML SETLİ(PVC), POLİFLEKS 100 MG/ML DEKSTRAN 40+9 MG/ML İZOTONİK SODYUM KLORÜR I.V. İNFÜZYON İÇİN ÇÖZELTİ, 100 ML SETSİZ(PVC)Salmeterol
go.drugbank.com/drugs/DB00938ApprovedInvestigational[A190477] Salmeterol's structure is similar to salbutamol's with an aralkyloxy-alkyl substitution on the amine.[A183737] Salmeterol was granted FDA approval on 4 February 1994.[L11542]
Mixtures: AIRTIDE 100 MCG/50 MCG INHALASYON IÇIN TOZ IÇEREN KAPSÜL,60 ADET, SERETIDE 50/100 ACCUHALER 50 mcg/100 mcgCategories: Agents to Treat Airway Disease, Cytochrome P-450 SubstratesCorifollitropin alfa
go.drugbank.com/drugs/DB09066ApprovedInvestigationalThis means that it is made by cells into which a DNA has been introduced that makes them able to produce corifollitropin alfa [L2270]. … Corifollitropin alfa, also known as _Elonva_ is used in women undergoing fertility treatment to stimulate the development of more than one mature egg (oocyte) at a time in the ovaries.
Products: ELONVA® 100 MCG/0.5 ML. SOLUCION PARA INYECCION, ELONVA 150 MCG/0,5 ML ENJEKSIYONLUK COZELTI, 1 ADETClotrimazole
go.drugbank.com/drugs/DB00257ApprovedInvestigationalVet approvedThe minimal side effect profile of this drug and its uncomplicated metabolic profile have led it to gain widespread acceptance for the treatment of mycotic outbreaks such as vaginal yeast infections as
Mixtures: Imazol duo 10 mg/g + 2,5 mg/g Creme, BETAMETASONA 0.04% + CLOTRIMAZOL 1.0% + NEOMICINA 0.5% CREMA TÓPICACategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2B6 Inducers